Skip to main content

Ransomware victim disclosure

All victims

Unknown Pharmaceutical Company

Claimed by Rhysida · listed 3 days ago

~5.8 TB
Data size
2899290 files records
3d
Age
since listed · listed for ransom

Status timeline

  1. ListedSep 10, 2026

Current state: Listed for ransom

At a glance

Group
Rhysida
Status
Listed for ransom
Listed on leak site
Sep 10, 2026
Data size
~5.8 TB
Records
2899290 files

About the victim

AI dossier — public-source company profile

An unknown pharmaceutical company involved in narcotics and controlled-substance manufacturing or distribution. The company maintains regulated pharmacovigilance records and government compliance documentation. Scale and specific location are undetermined from available evidence.

Industry
Pharmaceutical Manufacturing & Distribution

Attack summary

Severity: critical — Alleged exfiltration of controlled-substance records (DEA-regulated narcotics including opioids), employee PII at scale (SSNs, addresses, DOB), executive data, and pharmacovigilance records. The combination of regulated pharmaceutical data, controlled-substance documentation, and sensitive personal information constitutes critical exposure under healthcare and drug-enforcement regulatory frameworks.

Rhysida claims to have exfiltrated approximately 2.9 million files totaling ~5.8 TB from the company. The group alleges access to accounting records, database backups, government audit files, corporate ownership documents, narcotics/controlled-substance records, litigation files, executive and employee personal data, IT artifacts, and pharmacovigilance correspondence.

critical

Data the group says was taken

AI dossier — extracted from the leak post
  • accounting records and database backups
  • government audits (customs, corporate tax, social security, wage tax)
  • corporate ownership and beneficial-ownership filings
  • narcotics/BtM records (opioids, cannabis, precursors)
  • litigation files
  • executive and employee personal data
  • IT artifacts
  • pharmacovigilance correspondence

What the group claims

Pharmaceutical company with accounting records, government audit files, corporate ownership documents, narcotics/BtM records, litigation files, executive and employee personal data, IT artifacts, and pharmacovigilance correspondence.

The leak post

captured from the group's site
814,500 files, 2.6 TB721 background-check dossiers with full SSNs in filenames, including 2026 records.Tens of thousands of medical faxes, 2022 to 2026, with patient names and diagnoses.Methadone clinic records under 42 CFR Part 2, the strictest US confidentiality regime.47,602 medical-assistance files with driver licenses, Green Cards, SSN cards, tax forms and bank data.County payroll registers with all salaries, HR memos, contracts, pension and discipline databases.Jail gang-intelligence files with a gang-member master list.
With just 7 days on the clock, seize the opportunity to bid on exclusive, unique, and impressive data. Open your wallets and be ready to buy exclusive data. We sell only to one hand, no reselling, you will be the only owner!
Total files 338,542Total size 710.6 GBFull corporate bank account details (account, routing, SWIFT) in letters and hand-filled ACH/EFT forms signed by accountingCorporate EIN on a current signed W-9Client trust account (IOLTA) statements with account numbersACH/EFT authorizations from major insurance clients; settlement wire confirmations; check copiesComplete Positive Pay register � all firm payments with payees and amountsPartners' corp…

Data the group says was taken

  • accounting records
  • database backups
  • government audit files
  • corporate ownership documents
  • beneficial-ownership filings
  • narcotics records
  • litigation files
  • executive personal data
  • employee personal data
  • IT artifacts
  • pharmacovigilance correspondence

Screenshot of the leak post

Leak screenshot for Unknown Pharmaceutical Company

Sources

Source

Indexed 3 days ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About Rhysida

Rhysida is a ransomware group that emerged in June 2023, operating with primarily financial motivations through targeted attacks against critical infrastructure and public sector organizations. The group's origin and potential state affiliations remain unclear, though they operate independently rather than as a traditional Ransomware-as-a-Service model, with limited public documentation regarding connections to other cybercriminal organizations. Rhysida employs double extortion tactics, typically gaining initial access through compromised VPN credentials and exploiting vulnerable public-facing applications before deploying their ransomware payload and exfiltrating sensitive data prior to encryption. The group has demonstrated a particular focus on healthcare and educational institutions, with notable attacks documented by CISA and FBI advisories highlighting their targeting of hospitals and school districts across multiple countries, resulting in significant operational disruptions to critical services. As of late 2024, Rhysida remains an active threat with continued operations targeting organizations primarily in the United States, Canada, and other Western nations, maintaining their focus on high-value sectors where operational disruption can maximize ransom payment likelihood. The group has been linked to 324 public disclosures across our corpus. First observed on a leak site on June 5, 2023; most recent post September 13, 2026. The operation is currently active.

Timeline of this disclosure

  • September 10, 2026Unknown Pharmaceutical Company listed by Rhysida on the group's public leak site
Data size
~5.8 TB
Records
2899290 files

Sector and geography

This disclosure adds to ransomware activity in the Pharmaceutical sector, which has 33 disclosures indexed across all operators we track.

If your organisation is affected

A listing by Rhysida means Unknown Pharmaceutical Company appeared on a ransomware extortion site and is being pressured to pay before any publication. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

  • Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
  • Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
  • Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
  • Monitor for the data appearing on Rhysida's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.